Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Biology|August 2, 2005
Loss of the serine/threonine kinase fused results in postnatal growth defects and lethality due to progressive hydrocephalusMark Merchant, Marie Evangelista, Shiuh-Ming Luoh, et al.
Endocrinology|August 24, 2002
Stanniocalcin 1 alters muscle and bone structure and function in transgenic miceEllen H Filvaroff, Susan Guillet, Constance Zlot, et al.
Cancer Management and Research|December 20, 2019
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced MalignancyPamela Munster, Monica Mita, Amit Mahipal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin LymphomaAntoine Hollebecque, Stefania Salvagni, Ruth Plummer, et al.
Cancer|June 23, 2022
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignanciesAntoine Hollebecque, Stefania Salvagni, Ruth Plummer, et al.
Cancer Cell|April 9, 2008
Blocking neuropilin-2 function inhibits tumor cell metastasisMaresa Caunt, Judy Mak, Wei-Ching Liang, et al.
Molecular Oncology|November 18, 2022
SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myelomaAlexander C Leeksma, Ingrid A M Derks, Brett Garrick, et al.
Blood|May 29, 2016
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemiaRachel Thijssen, Johanna Ter Burg, Brett Garrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic StrategiesEmanuela Dylgjeri, Christopher McNair, Jonathan F Goodwin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2019
DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling PathwayVishal Kothari, Jonathan F Goodwin, Shuang G Zhao, et al.
Pageof 3